Streetbeat News

Products Services

AMZN

BABA

EBAY

PDD

Pinduoduo's Temu has seen a surge in popularity in the U.S., with search interest reaching an all-time high. Analysts from Goldman Sachs and Jefferies have issued positive reviews on PDD stock, citing a 15%-30% upside potential. Despite its opaque financials and unconventional approach, Pinduoduo's direct-from-factory model sets it apart from competitors like eBay, Alibaba, and Amazon, contributing to its rapid growth. However, PDD's stock is down about 25% year-to-date.

Portfolio Pulse from Surbhi Jain

March 11, 2024 | 1:47 pm

NVDA

Nvidia CEO Jensen Huang emphasized the superiority of Nvidia's GPUs in the AI industry, stating they outperform even free competitor AI chips. He highlighted the company's role as an industry leader and collaborator, despite facing intense competition. Huang also discussed Nvidia's vision for AI's future, including the concept of 'AI factories' and the importance of 'Sovereign AI' for nations. Nvidia's stock closed 1.4% lower on Friday.

Portfolio Pulse from Rounak Jain

March 11, 2024 | 1:45 pm

AZN

INSM

On March 8, 2024, Insmed Incorporated received notice from AstraZeneca AB of the exercise of its second and final option under their 2016 License Agreement to develop and potentially commercialize brensocatib for COPD or asthma. This development allows AstraZeneca to proceed beyond Phase 2b clinical trials. Both companies retain discretion over the terms, including financial aspects, for further development and commercialization.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 1:35 pm

NVAX

Novavax announced that the Canada National Advisory Committee has published a recommendation for the use of its Nuvaxovid XBB.1.5 COVID-19 vaccine. The recommendation states that Nuvaxovid XBB.1.5 is suitable for use in both unvaccinated and previously vaccinated individuals aged 12 years and older.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 1:24 pm

MESO

Mesoblast Limited (NASDAQ:MESO) stock surged 17.2% in premarket trading after announcing FDA support for an accelerated approval pathway for rexlemestrocel-L for end-stage ischemic heart failure with reduced ejection fraction (HFrEF) and a left ventricular assist device (LVAD). The LVAD-MPC Study #2 showed significant benefits of rexlemestrocel-L over placebo in reducing mortality and improving weaning off LVAD support. Mesoblast plans to request a pre-BLA meeting with the FDA to discuss accelerated approval filing.

Portfolio Pulse from Vandana Singh

March 11, 2024 | 1:24 pm

NVAX

Novavax, Inc. announced that the Canada National Advisory Committee has published a recommendation for the use of Novavax's Nuvaxovid XBB.1.5 COVID-19 vaccine. The recommendation states that Nuvaxovid XBB.1.5 can be used in both unvaccinated or previously vaccinated individuals aged 12 years and older.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 1:21 pm

BLUE

Bluebird Bio's stock is trading higher following the announcement of an outcomes-based agreement with Medicaid for its sickle cell disease gene therapy.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 1:14 pm

GRYP

Gryphon Digital Mining announced its operational update for February, reporting the production of approximately 52 Bitcoin. This update highlights the company's ongoing mining operations and its contribution to the cryptocurrency mining industry.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 1:07 pm

TTEC

TTEC Holdings Inc. (NASDAQ:TTEC) has been awarded a contract by PenFed Credit Union to modernize its member services contact center platform to Genesys Cloud for voice communications. This project includes integration between Genesys Cloud and Salesforce through TTEC Digital's OneView, enhancing service speed and quality. TTEC Digital, known for its AI-enabled CX solutions, has a long-standing partnership with Genesys, earning Partner of the Year recognition 13 times.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 1:07 pm

EMR

Emerson (NYSE:EMR) has been selected by H2 Hauler, an Australian company specializing in hydrogen storage and distribution, to provide a comprehensive hydrogen mobility business management system. This partnership aims to automate and integrate H2 Hauler's operations, enhancing the safety, efficiency, and sustainability of hydrogen transport. Emerson's technology will support H2 Hauler's expansion in hydrogen road transport and storage manufacturing, offering solutions like the DeltaV PK Controller, fire and gas systems, and a cloud-based data platform for real-time operational performance.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 1:06 pm